Clinical Trials

At Holy Redeemer Bott Cancer Center, we're always looking for better ways to prevent, diagnose and treat cancer. Our participation in clinical trials furthers our knowledge and gives you the opportunity to contribute to the advancement of cancer care, while receiving the latest treatment options from clinical experts.

Why Participate in a Clinical Trial?

People participate in clinical trials with hope for:

  • A new, effective treatment
  • Extending life
  • Relieving pain or other symptoms
  • Contributing to advances that will help others

If you are eligible for a clinical trial, the choice to participate is always yours. We encourage you to discuss participation with your family members and physician.

Advancing Cancer Care through Clinical Trials

Clinical research — research studies with people — is essential before making a new cancer treatment widely available to the general public.

Our Institutional Review Board of highly qualified physicians, pharmacists and others thoroughly reviews each clinical trial, applying the strictest quality standards to protect the well-being of our volunteer participants.

Past clinical trials have taught us much of what we know about cancer and its treatment. Volunteers in current clinical trials are paving the way for tomorrow’s cancer prevention, diagnosis and treatments. We are grateful to the many people who have contributed to our enhanced knowledge.

Access to National Trials

Through our membership with MD Anderson Cooper, we offer you access to national clinical trials with promising new treatments.

We have access to:

  • Trials sponsored by the National Cancer Institute
  • Select trials supported by the National Institutes of Health

Is a Clinical Trial Right for You?

Each trial has its own guidelines for eligibility. Speak to your doctor or contact our Clinical Trial Nurse at 215-938-3551 to find out if we offer a trial that is right for you.

Holy Redeemer Hospital Clinical Trials


BWEL Study: Breast Cancer Weight Loss Study.

A011502: Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy.

A011505: Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer.

EA1131: Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy.

NSABP B51: Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery.

A011104: MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer.


EAY131: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial).

Other Studies

Lung Cancer Screening Program Using Low Dose CT Scan with Prospective Patient Outcome Data Collection: The National Cancer Institute (NCI) conducted a large national lung screening trial (NLST), which showed a benefit in detecting lung cancer earlier in heavy smokers using LDCT. Essentially, it comes down to how long and how much you have smoked in your lifetime. Currently, this screening test is covered by most insurances.  When you call to make an appointment we will work with you to determine your specific coverage.

For more information, call 215-938-LUNG or click here.

For more information on Clinical Trials, please visit the following websites: